Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2008 Jan-Feb;15 Suppl A(Suppl A):1A-8A.
doi: 10.1155/2008/641965.

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care

Denis E O'Donnell  1 , Paul Hernandez, Alan Kaplan, Shawn Aaron, Jean Bourbeau, Darcy Marciniuk, Meyer Balter, Gordon Ford, Andre Gervais, Yves Lacasse, Francois Maltais, Jeremy Road, Graeme Rocker, Don Sin, Tasmin Sinuff, Nha Voduc
Affiliations
Practice Guideline

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care

Denis E O'Donnell et al. Can Respir J. 2008 Jan-Feb.

Abstract
in English, French

Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Canada that is preventable and treatable but unfortunately remains underdiagnosed. The purpose of the present article from the Canadian Thoracic Society is to provide up-to-date information so that patients with this condition receive optimal care that is firmly based on scientific evidence. Important summary messages for clinicians are derived from the more detailed Update publication and are highlighted throughout the document. Three key messages contained in the update are: use targeted screening spirometry to establish a diagnosis and initiate prompt management (including smoking cessation) of mild COPD; improve dyspnea and activity limitation in stable COPD using new evidence-based treatment algorithms; and understand the importance of preventing and managing acute exacerbations, particularly in moderate to severe disease.

La maladie pulmonaire obstructive chronique (MPOC) est une grave maladie respiratoire au Canada. Elle peut être prévenue et traitée, mais demeure malheureusement sous-diagnostiquée. Le présent article de la Société canadienne de thoracologie vise à fournir de l’information à jour pour que les patients atteints de cette maladie reçoivent des soins optimaux solidement étayés par des preuves scientifiques. Des messages résumés importants à l’intention des cliniciens sont tirés de la mise à jour plus détaillée et soulignés tout au long du document. La mise à jour contient trois messages clés : utiliser la spirométrie de dépistage ciblée pour diagnostiquer et prendre rapidement en charge la MPOC bénigne (y compris le renoncement au tabac), réduire la dyspnée et les contraintes aux activités en cas de MPOC stable au moyen de nouveaux algorithmes de traitement probants et comprendre l’importance de la prévention et de la prise en charge des exacerbations aiguës, notamment en présence d’une maladie modérée à grave.

PubMed Disclaimer

Figures

Figure 1)
Figure 1)
A comprehensive approach to the management of chronic obstructive pulmonary disease (COPD). AECOPD Acute exacerbation of COPD; LABA Long-acting beta2-agonist; MRC Medical Research Council; PRN As needed; Rx Treatment
Figure 2)
Figure 2)
Recommendations for optimal pharmacotherapy in chronic obstructive pulmonary disease (COPD). *Refers to the lower dose inhaled corticosteroid/long-acting beta2-agonist (ICS/LABA). AECOPD Acute exacerbation of COPD; LAAC Long-acting anticholinergic; prn As needed; SABA Short-acting beta2-agonist; SABD Short-acting bronchodilator
See this image and copyright information in PMC

Comment in

Publication types

MeSH terms

Substances